Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Risk of over- And under- treatment with levothyroxine in primary care in Copenhagen, Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. THERAPY OF ENDOCRINE DISEASE: Growth hormone replacement therapy in adults: 30 years of personal clinical experience

    Research output: Contribution to journalReviewResearchpeer-review

  4. Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. SGLT2 inhibitors: Clinical benefits by restoration of normal diurnal metabolism?

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations
Fibroblast growth factor 21 (FGF21) is a metabolic factor involved in glucose and lipid metabolism. However, little is known about the physiological role of FGF21 during a dietary challenge in humans.
Original languageEnglish
JournalEuropean Journal of Endocrinology
Volume167
Issue number1
Pages (from-to)49-57
Number of pages9
ISSN0804-4643
DOIs
Publication statusPublished - 2012

    Research areas

  • Adipose Tissue, Adult, Blood Glucose, Cross-Over Studies, Diet, High-Fat, Energy Metabolism, Fibroblast Growth Factors, Humans, Hyperphagia, Infant, Low Birth Weight, Infant, Newborn, Insulin, Insulin Resistance, Male, Muscle, Skeletal

ID: 36878836